Analyst price target range
Immunovant Price Target: $48.88 Average
Direct answer
Immunovant's average price target is $48.88.
The verified analyst range runs from $30.00 to $66.00.
The low target implies -18.1%, the high target implies +80.1%, and the range spans 98.2% of the current price.
Forecast evidence checked September 16, 2026.
Get free Immunovant email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $36.65
- Average price target
- $48.88
- High price target
- $66.00
- Low price target
- $30.00
- Low target gap
- -18.1%
- Target upside
- +33.4%
- High target gap
- +80.1%
- Target range width
- 98.2%
- Consensus rating
- none
- Analysts
- 16
- Evidence date
- September 16, 2026
- Valid through
- September 23, 2026
Explore related company data
Read the frequently asked questions.
What is Immunovant's average price target?
Immunovant's verified average price target is $48.88. The target range is $30.00 to $66.00.
How far are Immunovant's low and high targets from the recorded price?
The low target implies -18.1%, while the high target implies +80.1%.
How many analysts are included in Immunovant's consensus?
The verified consensus includes 16 analysts.
How is Immunovant's target upside or downside calculated?
The average target of $48.88 is divided by the recorded price of $36.65, then one is subtracted to produce +33.4%. This does not guarantee a future return.
When was Immunovant's analyst forecast verified?
The data was verified on 2026-09-16. The dataset is valid through 2026-09-23.